• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适当的抗生素治疗可改善新生儿鼠解脲脲原体败血症的结局。

Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse.

机构信息

Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

出版信息

Pediatr Res. 2012 Nov;72(5):502-6. doi: 10.1038/pr.2012.115. Epub 2012 Aug 20.

DOI:10.1038/pr.2012.115
PMID:22907617
Abstract

BACKGROUND

Ureaplasma causes sepsis in human neonates. Although erythromycin has been the standard treatment, it is not always effective. No published reports have evaluated Ureaplasma sepsis in a neonatal model. We hypothesized that appropriate antibiotic treatment improves Ureaplasma sepsis in a neonatal mouse model.

METHODS

Two ATCC strains and two clinical strains of Ureaplasma were evaluated in vitro for antibiotic minimum inhibitory concentration (MIC). In addition, FVB albino mice pups infected with Ureaplasma were randomly assigned to saline, erythromycin, or azithromycin therapy and survival, quantitative blood culture, and growth were evaluated.

RESULTS

MICs ranged from 0.125 to 62.5 µg/ml and 0.25 to 1.0 µg/ml for erythromycin and azithromycin, respectively. The infecting strain and antibiotic selected for treatment appeared to affect survival and bacteremia, but only the infecting strain affected growth. Azithromycin improved survival and bacteremia against each strain, whereas erythromycin was effective against only one of four strains.

CONCLUSION

We have established a neonatal model of Ureaplasma sepsis and observed that treatment outcome is related to infecting strain and antibiotic treatment. We speculate that appropriate antibiotic selection and dosing are required for effective treatment of Ureaplasma sepsis in neonates, and this model could be used to further evaluate these relationships.

摘要

背景

脲原体可导致人类新生儿败血症。尽管红霉素一直是标准治疗方法,但并不总是有效。尚无文献报道评估过新生儿模型中的脲原体败血症。我们假设适当的抗生素治疗可改善新生儿脲原体败血症模型中的脲原体败血症。

方法

我们评估了 ATCC 株和两株临床分离株脲原体的体外抗生素最小抑菌浓度(MIC)。此外,用脲原体感染 FVB 白化鼠幼仔,然后将其随机分为盐水、红霉素或阿奇霉素治疗组,并评估其存活率、定量血培养和生长情况。

结果

红霉素和阿奇霉素的 MIC 值分别为 0.125 至 62.5μg/ml 和 0.25 至 1.0μg/ml。感染株和所选抗生素似乎影响存活率和菌血症,但只有感染株影响生长。阿奇霉素改善了对每种菌株的存活率和菌血症,而红霉素仅对四种菌株中的一种有效。

结论

我们建立了新生儿脲原体败血症模型,并观察到治疗结果与感染株和抗生素治疗有关。我们推测,新生儿脲原体败血症的有效治疗需要选择合适的抗生素并进行适当的剂量调整,该模型可用于进一步评估这些关系。

相似文献

1
Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse.适当的抗生素治疗可改善新生儿鼠解脲脲原体败血症的结局。
Pediatr Res. 2012 Nov;72(5):502-6. doi: 10.1038/pr.2012.115. Epub 2012 Aug 20.
2
Antibiotic prophylaxis improves Ureaplasma-associated lung disease in suckling mice.抗生素预防可改善乳鼠中与脲原体相关的肺部疾病。
Pediatr Res. 2009 Aug;66(2):197-202. doi: 10.1203/PDR.0b013e3181aabd34.
3
Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents.解脲脲原体新生儿呼吸道分离株对抗菌药物的敏感性
Antimicrob Agents Chemother. 1998 May;42(5):1290-2. doi: 10.1128/AAC.42.5.1290.
4
Antibiotic susceptibilities and resistance genes of Ureaplasma parvum isolated in South Africa.南非分离的解脲脲原体的抗生素敏感性和耐药基因。
J Antimicrob Chemother. 2012 Dec;67(12):2821-4. doi: 10.1093/jac/dks314. Epub 2012 Aug 9.
5
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.解脲脲原体对四环素、多西环素、红霉素、罗红霉素、克拉霉素、阿奇霉素、左氧氟沙星和莫西沙星的敏感性。
J Chemother. 2011 Apr;23(2):77-9. doi: 10.1179/joc.2011.23.2.77.
6
[Voice on the treatment of ureaplasmas infections].[关于解脲脲原体感染治疗的语音]
Przegl Epidemiol. 2009;63(1):85-8.
7
Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.临床解脲脲原体和微小脲原体分离株在生物膜形成及抗生素敏感性方面的差异。
J Antimicrob Chemother. 2008 Nov;62(5):1027-30. doi: 10.1093/jac/dkn337. Epub 2008 Aug 27.
8
In vitro activities of erythromycin, tetracycline and levofloxacin alone and in dual combinations against ureaplasma spp.单独使用和联合使用红霉素、四环素和左氧氟沙星对解脲支原体的体外活性
Chemotherapy. 2011;57(2):128-33. doi: 10.1159/000323629. Epub 2011 Mar 24.
9
In vitro activity of solithromycin and its metabolites, CEM-214 and N-acetyl-CEM-101, against 100 clinical Ureaplasma spp. isolates compared with azithromycin.体外研究索利霉素及其代谢物 CEM-214 和 N-乙酰-CEM-101 对 100 株临床解脲支原体分离株的活性与阿奇霉素的比较。
Int J Antimicrob Agents. 2015 Sep;46(3):319-24. doi: 10.1016/j.ijantimicag.2015.04.015. Epub 2015 Jun 19.
10
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.同时进行脲原体属抗生素耐药性滴定和测定,并鉴定与耐药性相关基因中的新点突变。
Antimicrob Agents Chemother. 2009 May;53(5):2020-7. doi: 10.1128/AAC.01349-08. Epub 2009 Mar 9.

引用本文的文献

1
The benefits, limitations and opportunities of preclinical models for neonatal drug development.新生儿药物开发的临床前模型的优势、局限性和机遇。
Dis Model Mech. 2022 Apr 1;15(4). doi: 10.1242/dmm.049065. Epub 2022 Apr 25.
2
Nucleic acid aptamer controls mycoplasma infection for inhibiting the malignancy of esophageal squamous cell carcinoma.核酸适体通过控制支原体感染抑制食管鳞癌细胞的恶性转化。
Mol Ther. 2022 Jun 1;30(6):2224-2241. doi: 10.1016/j.ymthe.2022.02.018. Epub 2022 Feb 18.
3
Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model.
解脲脲原体在实验性免疫受损小鼠模型中导致高氨血症。
PLoS One. 2016 Aug 18;11(8):e0161214. doi: 10.1371/journal.pone.0161214. eCollection 2016.
4
Gastric fluid versus amniotic fluid analysis for the identification of intra-amniotic infection due to Ureaplasma species.胃液与羊水分析用于鉴定解脲脲原体引起的羊膜腔内感染。
J Matern Fetal Neonatal Med. 2016;29(16):2579-87. doi: 10.3109/14767058.2015.1098614. Epub 2015 Dec 2.
5
Neonatal Ureaplasma urealyticum colonization increases pulmonary and cerebral morbidity despite treatment with macrolide antibiotics.尽管使用了大环内酯类抗生素治疗,但新生儿解脲脲原体定植仍会增加肺部和脑部发病率。
Infection. 2016 Jun;44(3):323-7. doi: 10.1007/s15010-015-0858-7. Epub 2015 Oct 30.
6
Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques.足月临床绒毛膜羊膜炎I:运用培养和分子技术对羊膜腔进行微生物学研究
J Perinat Med. 2015 Jan;43(1):19-36. doi: 10.1515/jpm-2014-0249.
7
Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization.多剂量静脉注射阿奇霉素在有脲原体呼吸道定植风险的早产儿中的药代动力学、微生物反应及肺部转归
Antimicrob Agents Chemother. 2015 Jan;59(1):570-8. doi: 10.1128/AAC.03951-14. Epub 2014 Nov 10.